Director, Pharmacokinetics Dr. Vince Clinical Research
Learning Labs have limited capacity and rooms will fill up quickly! Arrive early to ensure you can secure your spot.
Understanding pharmacokinetics (PK) is essential for optimizing drug development strategies, improving patient outcomes, and enhancing clinical trial design. This session will explore practical approaches to leveraging PK tools to inform dosing decisions, streamline the clinical development program, and reduce burden on patients and subjects. Dr. Toni Grant will discuss innovative modeling techniques, study design considerations, and best practices for maximizing efficiency.
Learning Objectives: 1. Understand the role of pharmacokinetics in drug development. 2. Explore the use of PK to guide dose selection and enhance clinical trial efficiency. 3. Identify strategies for optimizing study design to reduce patient/subject burden. 4. Learn how PK modeling can be used to inform study design and streamline clinical development.
Brought to you by:
This event is sponsored by an ASCPT Partner organization. The content of the session is provided for informational purposes only and does not constitute or imply ASCPT's endorsement, recommendation, or approval of a specific institution, service, employer, or content.